Today

Agents

Chat

Arena

Discover

More

App

Liminatus Pharma moves Nasdaq listing to Capital Market tier - LIMN News | Rallies

Liminatus Pharma moves Nasdaq listing to Capital Market tier

LIMN•2026-08-13

Nasdaq listing transferred to Capital Market tier

Liminatus Pharma moved its Nasdaq listing to the Nasdaq Capital Market, effective Aug. 4, 2026.

Shares continue trading on Nasdaq under the LIMN ticker following the transfer.

Nasdaq granted an extension to regain the minimum bid price requirement, setting a Sept. 3, 2026 deadline.

Related News

PAVmed subsidiary Lucid Diagnostics posts 2Q revenue of USD 1.5 million

LUCD•2026-08-13

ZenaTech signs first paying AI data center construction customer for ZenaWorx drone monitoring service

ZENA•2026-08-13

BUZZ-U.S. Stocks on the Move-Five Below, Salesforce, IBM, Akamai Technologies

SPY

•

2026-08-13

American Express expands Conferma partnership for BTA virtual card payments

AXP•2026-08-13

SCI Engineered Materials CFO Shelby Yohn resigns, stays on as accounting director

SCIA•2026-08-13